Saint Sean
President & CEO
Saint Sean has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Saint Sean is listed as President & CEO at Beta Bionics, Inc. Inside the rolling window, Saint Sean reported no open-market purchases and 4 open-market sales totaling $673K in BBNX. The largest disclosed transaction in the window is a sale of 16,867 BBNX shares on Sep 2, 2026, worth $322K.
Companies traded
Other insiders at BBNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$673K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Saint Sean made?
Saint Sean has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Saint Sean trade?
Saint Sean has filed SEC Form 4 disclosures for 1 company, including BBNX.
When was Saint Sean's most recent SEC Form 4 filing?
Saint Sean's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Saint Sean's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Saint Sean is listed as President & CEO.
What is Saint Sean's total buy and sell value in the current window?
Inside the rolling retention window, Saint Sean bought $0 and sold $673K based on SEC Form 4 filings.
What was Saint Sean's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 16,867 BBNX shares on 2026-09-02, worth $322K, per SEC Form 4 filings.